MTHFR C677T and A1298C polymorphisms as predictors of radiotherapy response in head and neck squamous cell carcinoma

dc.contributor.authorAnders, Q. S.
dc.contributor.authorStur, E.
dc.contributor.authorAgostini, Lidiane Pignaton
dc.contributor.authorGarcia, F. M.
dc.contributor.authorReis, R. S.
dc.contributor.authorSantos, J. A.
dc.contributor.authorMendes, S. O.
dc.contributor.authorMaia, L. L.
dc.contributor.authorPeterle, G. T.
dc.contributor.authorStange, V.
dc.contributor.authorCarvalho, M. B.
dc.contributor.authorTajara, E. H.
dc.contributor.authorSantos, Marcelo dos
dc.contributor.authorSilva-Conforti, A. M. A.
dc.contributor.authorLouro, I. D.
dc.date.accessioned2021-02-11T16:24:40Z
dc.date.available2021-02-11T16:24:40Z
dc.date.issued2015-10-26
dc.description.resumoThe C677T and A1298C polymorphisms in methylenetetrahydrofolate reductase (MTHFR), which regulates the release of active folate in the body, may have reduced activity. Given that folate participates in important intracellular pathways, such as nucleotide synthesis and biomolecule methylation, it seems plausible that patients with head and neck squamous cell carcinoma (HNSCC) may respond differently to radiotherapy treatments, based on genetic polymorphisms. Therefore, this study sought to understand the role of these polymorphisms in HNSCC patient radiotherapy response. Genotypes were detected by PCR-RFLP after extraction of DNA from peripheral blood lymphocytes. Survival curves were analyzed by the KaplanMeier model, and significant differences were analyzed by the Wilcoxon test. Response to radiotherapy in patients with laryngeal SCC was significantly associated with the MTHFR C677T polymorphism (P = 0.030). Indeed, the presence of at least one T allele decreases the mortality rate up to 3-fold. Therefore, we propose that MTHFR C677T may represent a putative biomarker for radiotherapy prognosis in laryngeal SCC patientspt_BR
dc.identifier.citationSANTOS, Marcelo dos; ANDERS, Q. S.; STUR, E.; AGOSTINI, L. P.; GARCIA, F. M.; REIS, R. S.; SANTOS, J. A.; MENDES, S. O.; MAIA, L. L.; PETERLE, G. T.; STANGE, V.; CARVALHO, M. B.; TAJARA, E. H.; SILVA-CONFORTI, A. M. A.; LOURO, I. D. MTHFR C677T and A1298C polymorphisms as predictors of radiotherapy response in head and neck squamous cell carcinoma. Genetics and Molecular Research, [s. l.], v. 14, n. 4. p. 13105-13109, 2015. Disponível em: https://www.geneticsmr.com/sites/default/files/articles/year2015/vol14-4/pdf/gmr6252.pdf. Acesso em: 07 jul. 2020. http://dx.doi.org/10.4238/2015.October.26.6pt_BR
dc.identifier.doi10.4238/2015.October.26.6
dc.identifier.issn1676-5680 (print)
dc.identifier.urihttps://repositorio.ufrn.br/handle/123456789/31481
dc.languageenpt_BR
dc.publisherFundação de Pesquisas de Ribeirão Pretopt_BR
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 Brazil*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/br/*
dc.subjectMTHFRpt_BR
dc.subjectHead and neck cancerpt_BR
dc.subjectRadiotherapypt_BR
dc.titleMTHFR C677T and A1298C polymorphisms as predictors of radiotherapy response in head and neck squamous cell carcinomapt_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
PolymorphismsPredictorsRadiotherapy_Santos_2015.pdf
Tamanho:
327.66 KB
Formato:
Adobe Portable Document Format
Carregando...
Imagem de Miniatura
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar